Medical Aesthetics
-
NCT00168415 - A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis
-
NCT00168480 - A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis
-
NCT00243542 - Phase IV Study to Gather More Information About the Safety of ACZONE® Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency
-
NCT00343187 - A Phase II Study of ACZONE® (Dapsone) Gel, 5% As a Treatment For TarcevaŽ (Erlotinib)Related Rash
-
NCT00249782 - A Phase II, Randomized Study of ACZONE® (Dapsone) Gel, 5% for Papulopustular Rosacea
-
NCT00151541 - A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%